Endotoxemia-menace, marker, or mistake?

Journal of Leukocyte Biology

Volumn 100, Issue 4, 2016, Pages 687-698

  Munford, Robert S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Endotoxin; Limulus; Lipopolysaccharide; LPS; Translocation

Indexed keywords

ENDOTOXIN; ENDOTOXIN ANTIBODY; LIPID A; LIPOPOLYSACCHARIDE; O ANTIGEN; OLIGOSACCHARIDE; PLASMA PROTEIN; ACYLOXYACYL HYDROLASE; CARBOXYLESTERASE;

BIOLOGICAL ACTIVITY; BLOODBORNE BACTERIUM; ENDOTOXEMIA; HOST CELL; HUMAN; IMMUNE RESPONSE; LYMPH; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; BLOOD; CHEMISTRY; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; INTESTINE ABSORPTION; LIMULUS LYSATE TEST; METABOLISM; PATHOGENICITY; SERODIAGNOSIS; STRUCTURE ACTIVITY RELATION; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CARBOXYLIC ESTER HYDROLASES; ENDOTOXEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTESTINAL ABSORPTION; LIMULUS TEST; LIPID A; LIPOPOLYSACCHARIDES; LYMPH; NEUTRALIZATION TESTS; O ANTIGENS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84990049629     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3RU0316-151R     Document Type: Review

References (152)

1. Suffredini, A. F., Fromm, R. E., Parker, M. M., Brenner, M., Kovacs, J. A., Wesley, R. A., Parrillo, J. E. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321, 280-287.
2. Marshall, J. C. (2005) Lipopolysaccharide: an endotoxin or an exogenous hormone? Clin. Infect. Dis. 41 (Suppl 7), S470-S480.
3. Hurley, J. C., Nowak, P., Öhrmalm, L., Gogos, C., Armaganidis, A., Giamarellos-Bourboulis, E. J. (2015) Endotoxemia as a diagnostic tool for patients with suspected bacteremia caused by gram-negative organisms: a meta-analysis of 4 decades of studies. J. Clin. Microbiol. 53, 1183-1191.
4. Opal, S. M., Scannon, P. J., Vincent, J. L., White, M., Carroll, S. F., Palardy, J. E., Parejo, N. A., Pribble, J. P., Lemke, J. H. (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis. 180, 1584-1589.
5. Shands, J. W., Jr.,Chun, P. W. (1980) The dispersion of gram-negative lipopolysaccharide by deoxycholate. Subunit molecular weight. J. Biol. Chem. 255, 1221-1226.
6. Schwechheimer, C., Kuehn, M. J. (2015) Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat. Rev. Microbiol. 13, 605-619.
7. Hellman, J., Roberts, J. D., Jr.,Tehan, M. M., Allaire, J. E., Warren, H. S. (2002) Bacterial peptidoglycan-associated lipoprotein is released into the bloodstream in gram-negative sepsis and causes inflammation and death in mice. J. Biol. Chem. 277, 14274-14280.
8. Magnuson, D. K., Weintraub, A., Pohlman, T. H., Maier, R. V. (1989) Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. J. Immunol. 143, 3025-3030.
9. Yoshimura, A., Kaneko, T., Kato, Y., Golenbock, D. T., Hara, Y. (2002) Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human Tolllike receptor 4. Infect. Immun. 70, 218-225.
10. Poxton, I. R., Edmond, D. M. (1995) Biological activity of Bacteroides lipopolysaccharide-reappraisal. Clin. Infect. Dis. 20 (Suppl 2), S149-S153.
11. Slocum, C., Coats, S. R., Hua, N., Kramer, C., Papadopoulos, G., Weinberg, E. O., Gudino, C. V., Hamilton, J. A., Darveau, R. P., Genco, C. A. (2014) Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation. PLoS Pathog. 10, e1004215.
12. Bennett, I. L., Jr.,Beeson, P. B. (1954) Bacteremia: a consideration of some experimental and clinical aspects. Yale J. Biol. Med. 26, 241-262.
13. Lu, M., Munford, R. S. (2011) The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo. J. Immunol. 187, 3314-3320.
14. Olofsson, P., Nylander, G., Olsson, P. (1986) Endotoxin: routes of transport in experimental peritonitis. Am. J. Surg. 151, 443-446.
15. Brandtzaeg, P., Bryn, K., Kierulf, P., Ovstebø, R., Namork, E., Aase, B., Jantzen, E. (1992) Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J. Clin. Invest. 89, 816-823.
16. Coureuil, M., Bourdoulous, S., Marullo, S., Nassif, X. (2014) Invasive meningococcal disease: a disease of the endothelial cells. Trends Mol. Med. 20, 571-578.
17. Øvstebø, R., Brandtzaeg, P., Brusletto, B., Haug, K. B., Lande, K., Høiby, E. A., Kierulf, P. (2004) Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J. Clin. Microbiol. 42, 2980-2987.
18. Simpson, A. J., Opal, S. M., Angus, B. J., Prins, J. M., Palardy, J. E., Parejo, N. A., Chaowagul, W., White, N. J. (2000) Differential antibiotic-induced endotoxin release in severe melioidosis. J. Infect. Dis. 181, 1014-1019.
19. Erridge, C. (2011) The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br. J. Nutr. 105, 15-23.
20. Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., Eckhardt, E. (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50, 90-97.
21. Van Deventer, S. J., ten Cate, J. W., Tytgat, G. N. (1988) Intestinal endotoxemia. Clinical significance. Gastroenterology 94, 825-831.
22. Erridge, C., Attina, T., Spickett, C. M., Webb, D. J. (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86, 1286-1292.
23. Van Deventer, S. J., Knepper, A., Landsman, J., Lawson, J., ten Cate, J. W., Buller, H. R., Sturk, A., Pauw, W. (1988) Endotoxins in portal blood. Hepatogastroenterology 35, 223-225.
24. Erridge, C. (2011) Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. Atherosclerosis 216, 1-6.
25. Moore, F. A., Moore, E. E., Poggetti, R., McAnena, O. J., Peterson, V. M., Abernathy, C. M., Parsons, P. E. (1991) Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J. Trauma 31, 629-636, discussion 636-638.
26. MacFie, J., O’Boyle, C., Mitchell, C. J., Buckley, P. M., Johnstone, D., Sudworth, P. (1999) Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45, 223-228.
27. Deitch, E. A. (2012) Gut-origin sepsis: evolution of a concept. Surgeon 10, 350-356.
28. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B. R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J. N., Hecht, F. M., Picker, L. J., Lederman, M. M., Deeks, S. G., Douek, D. C. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371.
29. Redd, A. D., Dabitao, D., Bream, J. H., Charvat, B., Laeyendecker, O., Kiwanuka, N., Lutalo, T., Kigozi, G., Tobian, A. A., Gamiel, J., Neal, J. D., Oliver, A. E., Margolick, J. B., Sewankambo, N., Reynolds, S. J., Wawer, M. J., Serwadda, D., Gray, R. H., Quinn, T. C. (2009) Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc. Natl. Acad. Sci. USA 106, 6718-6723.
30. Herieka, M., Erridge, C. (2014) High-fat meal induced postprandial inflammation. Mol. Nutr. Food Res. 58, 136-146.
31. Spadoni, I., Zagato, E., Bertocchi, A., Paolinelli, R., Hot, E., Di Sabatino, A., Caprioli, F., Bottiglieri, L., Oldani, A., Viale, G., Penna, G., Dejana, E., Rescigno, M. (2015) A gut-vascular barrier controls the systemic dissemination of bacteria. Science 350, 830-834.
32. Erridge, C., Spickett, C. M., Webb, D. J. (2007) Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2. Cardiovasc. Res. 73, 181-189.
33. Erridge, C. (2011) Accumulation of stimulants of Toll-like receptor (TLR)-2 and TLR4 in meat products stored at 5 °C. J. Food Sci. 76, H72-H79.
34. DIABIMMUNE Study Group. (2016) Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 1551.
35. Suffredini, A. F., Noveck, R. J. (2014) Human endotoxin administration as an experimental model in drug development. Clin. Pharmacol. Ther. 96, 418-422.
36. Bahador, M., Cross, A. S. (2007) From therapy to experimental model: a hundred years of endotoxin administration to human subjects. J. Endotoxin Res. 13, 251-279.
37. Munford, R. S. (2006) Severe sepsis and septic shock: the role of gramnegative bacteremia. Annu. Rev. Pathol. 1, 467-496.
38. Takeshita, S., Nakatani, K., Tsujimoto, H., Kawamura, Y., Sekine, I. (2000) Detection of circulating lipopolysaccharide-bound monocytes in children with gram-negative sepsis. J. Infect. Dis. 182, 1549-1552.
39. Roth, R. I., Levin, F. C., Levin, J. (1993) Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin. Infect. Immun. 61, 3209-3215.
40. Salden, H. J., Bas, B. M. (1994) Endotoxin binding to platelets in blood from patients with a sepsis syndrome. Clin. Chem. 40, 1575-1579.
41. Stahl, A. L., Svensson, M., Mörgelin, M., Svanborg, C., Tarr, P. I., Mooney, J. C., Watkins, S. L., Johnson, R., Karpman, D. (2006) Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108, 167-176.
42. Pöschl, J. M. B., Leray, C., Ruef, P., Cazenave, J. P., Linderkamp, O. (2003) Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit. Care Med. 31, 924-928.
43. Vesy, C. J., Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (2000) Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes. Infect. Immun. 68, 2410-2417.
44. Munford, R. S., Hall, C. L., Lipton, J. M., Dietschy, J. M. (1982) Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J. Clin. Invest. 70, 877-888.
45. Levels, J. H., Abraham, P. R., van den Ende, A., van Deventer, S. J. (2001) Distribution and kinetics of lipoprotein-bound endotoxin. Infect. Immun. 69, 2821-2828.
46. Yoshida, M., Roth, R. I., Levin, J. (1995) The effect of cell-free hemoglobin on intravascular clearance and cellular, plasma, and organ distribution of bacterial endotoxin in rabbits. J. Lab. Clin. Med. 126, 151-160.
47. Munford, R. S., Andersen, J. M., Dietschy, J. M. (1981) Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. J. Clin. Invest. 68, 1503-1513.
48. Shao, B., Munford, R. S., Kitchens, R., Varley, A. W. (2012) Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes. Innate Immun. 18, 825-833.
49. Triger, D. R., Boyer, T. D., Levin, J. (1978) Portal and systemic bacteraemia and endotoxaemia in liver disease. Gut 19, 935-939.
50. Findlay, L., Desai, T., Heath, A., Poole, S., Crivellone, M., Hauck, W., Ambrose, M., Morris, T., Daas, A., Rautmann, G., Buchheit, K. H., Spieser, J. M., Terao, E. (2015) Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354. Pharmeur. Bio. Sci. Notes 2015, 73-98.
51. Boutagy, N. E., McMillan, R. P., Frisard, M. I., Hulver, M. W. (2016) Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie 124, 11-20.
52. Levin, J., Tomasulo, P. A., Oser, R. S. (1970) Detection of endotoxin in human blood and demonstration of an inhibitor. J. Lab. Clin. Med. 75, 903-911.
53. Tsan, M. F., Gao, B. (2007) Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J. Endotoxin Res. 13, 6-14.
54. Erridge, C. (2010) Endogenous ligands of TLR2 and TLR4: agonists or assistants? J. Leukoc. Biol. 87, 989-999.
55. Gnauck, A., Lentle, R. G., Kruger, M. C. (2016) Chasing a ghost?-Issues with the determination of circulating levels of endotoxin in human blood. Crit. Rev. Clin. Lab. Sci. 53, 197-215.
56. Levin, J., Poore, T. E., Zauber, N. P., Oser, R. S. (1970) Detection of endotoxin in the blood of patients with sepsis due to gran-negative bacteria. N. Engl. J. Med. 283, 1313-1316.
57. Kambayashi, J., Yokota, M., Sakon, M., Shiba, E., Kawasaki, T., Mori, T., Tsuchiya, M., Oishi, H., Matsuura, S. (1991) A novel endotoxin-specific assay by turbidimetry with Limulus amoebocyte lysate containing betaglucan. J. Biochem. Biophys. Methods 22, 93-100.
58. Ding, J. L., Ho, B. (2010) Endotoxin detection-from Limulus amebocyte lysate to recombinant factor C. Subcell. Biochem. 53, 187-208.
59. Gnauck, A., Lentle, R. G., Kruger, M. C. (2015) The Limulus amebocyte lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects. J. Immunol. Methods 416, 146-156.
60. Gutsmann, T., Howe, J., Zähringer, U., Garidel, P., Schromm, A. B., Koch, M. H., Fujimoto, Y., Fukase, K., Moriyon, I., Martínez-de-Tejada, G., Brandenburg, K. (2010) Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells. Innate Immun. 16, 39-47.
61. Brandenburg, K., Howe, J., Gutsman, T., Garidel, P. (2009) The expression of endotoxic activity in the Limulus test as compared to cytokine production in immune cells. Curr. Med. Chem. 16, 2653-2660.
62. Schromm, A. B., Brandenburg, K., Loppnow, H., Moran, A. P., Koch, M. H. J., Rietschel, E. T., Seydel, U. (2000) Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem. 267, 2008-2013.
63. Takada, H., Kotani, S., Tanaka, S., Ogawa, T., Takahashi, I., Tsujimoto, M., Komuro, T., Shiba, T., Kusumoto, S., Kusunose, N., Hasegawa, A., Kiso, M. (1988) Structural requirements of lipid A species in activation of clotting enzymes from the horseshoe crab, and the human complement cascade. Eur. J. Biochem. 175, 573-580.
64. Dehus, O., Hartung, T., Hermann, C. (2006) Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J. Endotoxin Res. 12, 171-180.
65. Laude-Sharp, M., Haeffner-Cavaillon, N., Caroff, M., Lantreibecq, F., Pusineri, C., Kazatchkine, M. D. (1990) Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from gram-negative bacteria. Cytokine 2, 253-258.
66. Erwin, A. L., Mandrell, R. E., Munford, R. S. (1991) Enzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS. Infect. Immun. 59, 1881-1887.
67. Erwin, A. L. (1990) Studies of bacterial lipopolysaccharides and of a leukocyte lipopolysaccharide-deacylating enzyme, acyloxyacyl hydrolase. Ph.D. dissertation, University of Texas Southwestern Medical Center at Dallas.
68. Butler, T., Möller, G. (1977) Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of lipopolysaccharide by polymyxin B. Infect. Immun. 18, 400-404.
69. Butler, T., Levin, J., Linh, N. N., Chau, D. M., Adickman, M., Arnold, K. (1976) Yersinia pestis infection in Vietnam. II. Quantiative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J. Infect. Dis. 133, 493-499.
70. Butler, T., Bell, W. R., Levin, J., Linh, N. N., Arnold, K. (1978) Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch. Intern. Med. 138, 407-410.
71. Trautmann, M., Scheibe, C., Wellinghausen, N., Holst, O., Lepper, P. M. (2010) Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin. Chemotherapy 56, 364-370.
72. Katz, J., Zhang, P., Martin, M., Vogel, S. N., Michalek, S. M. (2006) Tolllike receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect. Immun. 74, 2809-2816.
73. Munford, R. S., Hall, C. L. (1979) Radioimmunoassay for Gram-negative bacterial lipopolysaccharide O antigens: influence of antigen solubility. Infect. Immun. 26, 42-48.
74. Jacobs, D. M., Gutowski, J. A. (1982) Solid-phase radioimmunoassay for bacterial lipopolysaccharide. Methods Enzymol. 84, 264-272.
75. Munford, R. S., Hall, C. L. (1987) A comparison of two quantitative assays for bacterial lipopolysaccharides. Prog. Clin. Biol. Res. 231, 93-102.
76. Munford, R. S., Hall, C. L., Grimm, L. (1984) Detection of free endotoxin in cerebrospinal fluid by the Limulus lysate test. Infect. Immun. 45, 531-533.
77. Mertsola, J., Cope, L. D., Munford, R. S., McCracken, G. H., Jr.,Hansen, E. J. (1991) Detection of experimental Haemophilus influenzae type b bacteremia and endotoxemia by means of an immunolimulus assay. J. Infect. Dis. 164, 353-358.
78. Müller-Loennies, S., Brade, L., MacKenzie, C. R., Di Padova, F. E., Brade, H. (2003) Identification of a cross-reactive epitope widely present in lipopolysaccharide from enterobacteria and recognized by the cross-protective monoclonal antibody WN1 222-5. J. Biol. Chem. 278, 25618-25627.
79. Gomery, K., Müller-Loennies, S., Brooks, C. L., Brade, L., Kosma, P., Di Padova, F., Brade, H., Evans, S. V. (2012) Antibody WN1 222-5 mimics Toll-like receptor 4 binding in the recognition of LPS. Proc. Natl. Acad. Sci. USA 109, 20877-20882.
80. Saxen, H., Vuopio-Varkila, J., Luk, J., Lindberg, A., Lang, A., Di Padova, F., Cryz, Jr., S. J., Mertsola, J., McCracken, G. H., Jr.,Hansen, E. J. (1993) Detection of enterobacterial lipopolysaccharides and experimental endotoxemia by means of an immunolimulus assay using both serotype-specific and cross-reactive antibodies. J. Infect. Dis. 168, 393-399.
81. Romaschin, A. D., Harris, D. M., Ribeiro, M. B., Paice, J., Foster, D. M., Walker, P. M., Marshall, J. C. (1998) A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. J. Immunol. Methods 212, 169-185.
82. Romaschin, A. D., Klein, D. J., Marshall, J. C. (2012) Bench-to-bedside review: clinical experience with the endotoxin activity assay. Crit. Care 16, 248.
83. Warren, H. S., Amato, S. F., Fitting, C., Black, K. M., Loiselle, P. M., Pasternack, M. S., Cavaillon, J.-M. (1993) Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J. Exp. Med. 177, 89-97.
84. Bhat, N. M., Bieber, M. M., Chapman, C. J., Stevenson, F. K., Teng, N. N. H. (1993) Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. J. Immunol. 151, 5011-5021.
85. Matsumoto, N., Takahashi, G., Kojika, M., Suzuki, Y., Inoue, Y., Inada, K., Endo, S. (2013) Interleukin-8 induces an elevation in the endotoxin activity assay (EAA) level: does the EAA truly measure the endotoxin level? J. Infect. Chemother. 19, 825-832.
86. Erridge, C., Duncan, S. H., Bereswill, S., Heimesaat, M. M. (2010) The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One 5, e9125.
87. Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., Camporez, J. P., Shulman, G. I., Gordon, J. I., Hoffman, H. M., Flavell, R. A. (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185.
88. Chassaing, B., Koren, O., Goodrich, J. K., Poole, A. C., Srinivasan, S., Ley, R. E., Gewirtz, A. T. (2015) Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519, 92-96.
89. Varley, A. W., Geiszler, S. M., Gaynor, R. B., Munford, R. S. (1997) A two-component expression system that responds to inflammatory stimuli in vivo. Nat. Biotechnol. 15, 1002-1006.
90. Maitra, S. K., Schotz, M. C., Yoshikawa, T. T., Guze, L. B. (1978) Determination of lipid A and endotoxin in serum by mass spectroscopy. Proc. Natl. Acad. Sci. USA 75, 3993-3997.
91. Szponar, B., Kraśnik, L., Hryniewiecki, T., Gamian, A., Larsson, L. (2003) Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin. Clin. Chem. 49, 1149-1153.
92. Pais de Barros, J. P., Gautier, T., Sali, W., Adrie, C., Choubley, H., Charron, E., Lalande, C., Le Guern, N., Deckert, V., Monchi, M., Quenot, J. P., Lagrost, L. (2015) Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the Limulus amebocyte lysate assay. J. Lipid Res. 56, 1363-1369.
93. Danner, R. L., Elin, R. J., Hosseini, J. M., Wesley, R. A., Reilly, J. M., Parillo, J. E. (1991) Endotoxemia in human septic shock. Chest 99, 169-175.
94. Gunti, S., Notkins, A. L. (2015) Polyreactive antibodies: function and quantification. J. Infect. Dis. 212 (Suppl 1), S42-S46.
95. The Sepsis Intervention Group. (1995) Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 274, 172-177.
96. Al-Bahrani, A. Z., Darwish, A., Hamza, N., Benson, J., Eddleston, J. M., Snider, R. H., Nylén, E. S., Becker, K. L., Barclay, G. R., Ammori, B. J. (2010) Gut barrier dysfunction in critically ill surgical patients with abdominal compartment syndrome. Pancreas 39, 1064-1069.
97. Barclay, G. R. (1995) Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. Prog. Clin. Biol. Res. 392, 263-272.
98. Bennett-Guerrero, E., Barclay, G. R., Youssef, M. E., Hossain, S., Vela-Cantos, F., Andres, L. A., Poxton, I. R. (2000) Exposure to Bacteroides fragilis endotoxin during cardiac surgery. Anesth. Analg. 90, 819-823.
99. Allan, E., Poxton, I. R., Barclay, G. R. (1995) Anti-Bacteroides lipopolysaccharide IgG levels in healthy adults and sepsis patients. FEMS Immunol. Med. Microbiol. 11, 5-12.
100. Hawkesworth, S., Moore, S. E., Fulford, A. J., Barclay, G. R., Darboe, A. A., Mark, H., Nyan, O. A., Prentice, A. M. (2013) Evidence for metabolic endotoxemia in obese and diabetic Gambian women. Nutr. Diabetes 3, e83.
101. Bennett-Guerrero, E., Barclay, G. R., Weng, P. L., Bodian, C. A., Feierman, D. E., Vela-Cantos, F., Mythen, M. G. (2001) Endotoxinneutralizing capacity of serum from cardiac surgical patients. J. Cardiothorac. Vasc. Anesth. 15, 451-454.
102. Warren, H. S., Novitsky, T. J., Ketchum, P. A., Roslansky, P. F., Kania, S., Siber, G. R. (1985) Neutralization of bacterial lipopolysaccharides by human plasma. J. Clin. Microbiol. 22, 590-595.
103. Bölke, E., Jehle, P. M., Storck, M., Nothnagel, B., Stanescu, A., Orth, K. (2001) Endotoxin release and endotoxin neutralizing capacity during colonoscopy. Clin. Chim. Acta 303, 49-53.
104. Champion, K., Chiu, L., Ferbas, J., Pepe, M. (2013) Endotoxin neutralization as a biomonitor for inflammatory bowel disease. PLoS One 8, e67736.
105. Marchetti, G., Tincati, C., Silvestri, G. (2013) Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev. 26, 2-18.
106. Sandler, N. G., Koh, C., Roque, A., Eccleston, J. L., Siegel, R. B., Demino, M., Kleiner, D. E., Deeks, S. G., Liang, T. J., Heller, T., Douek, D. C. (2011) Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 141, 1220-1230.
107. Bas, S., Gauthier, B. R., Spenato, U., Stingelin, S., Gabay, C. (2004) CD14 is an acute-phase protein. J. Immunol. 172, 4470-4479.
108. Meuleman, P., Steyaert, S., Libbrecht, L., Couvent, S., Van Houtte, F., Clinckspoor, F., de Hemptinne, B., Roskams, T., Vanlandschoot, P., Leroux-Roels, G. (2006) Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection. Clin. Chim. Acta 366, 156-162.
109. Bastian, D., Tamburstuen, M. V., Lyngstadaas, S. P., Reikeras, O. (2011) LBP and sCD14 patterns in total hip replacement surgery performed during combined spinal/epidural anaesthesia. Scand. J. Clin. Lab. Invest. 71, 486-491.
110. Møller, A. S., Bjerre, A., Brusletto, B., Joø, G. B., Brandtzaeg, P., Kierulf, P. (2005) Chemokine patterns in meningococcal disease. J. Infect. Dis. 191, 768-775.
111. Munford, R. S. (2005) Detoxifying endotoxin: time, place and person. J. Endotoxin Res. 11, 69-84.
112. Chen, K. T., Malo, M. S., Beasley-Topliffe, L. K., Poelstra, K., Millan, J. L., Mostafa, G., Alam, S. N., Ramasamy, S., Warren, H. S., Hohmann, E. L., Hodin, R. A. (2011) A role for intestinal alkaline phosphatase in the maintenance of local gut immunity. Dig. Dis. Sci. 56, 1020-1027.
113. Peterson, A. A., Munford, R. S. (1987) Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages. Infect. Immun. 55, 974-978.
114. Hampton, R. Y., Raetz, C. R. H. (1991) Macrophage catabolism of lipid A is regulated by endotoxin stimulation. J. Biol. Chem. 266, 19499-19509.
115. Shao, B., Lu, M., Katz, S. C., Varley, A. W., Hardwick, J., Rogers, T. E., Ojogun, N., Rockey, D. C., Dematteo, R. P., Munford, R. S. (2007) A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J. Biol. Chem. 282, 13726-13735.
116. Katz, S. S., Weinrauch, Y., Munford, R. S., Elsbach, P., Weiss, J. (1999) Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit inflammatory peritoneal exudate. J. Biol. Chem. 274, 36579-36584.
117. Weinrauch, Y., Katz, S. S., Munford, R. S., Elsbach, P., Weiss, J. (1999) Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate. Infect. Immun. 67, 3376-3382.
118. Lu, M., Varley, A. W., Munford, R. S. (2013) Persistently active microbial molecules prolong innate immune tolerance in vivo. PLoS Pathog. 9, e1003339.
119. Kitchens, R. L., Munford, R. S. (1995) Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270, 9904-9910.
120. Kitchens, R. L., Ulevitch, R. J., Munford, R. S. (1992) Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176, 485-494.
121. Lemaire, L. C. J. M., van Lanschot, J. J., van der Poll, T., Buurman, W. A., van Deventer, S. J. H., Gouma, D. J. (1998) Lymph of patients with a systemic inflammatory response syndrome inhibits lipopolysaccharide-induced cytokine production. J. Infect. Dis. 178, 883-886.
122. Yokochi, T., Inoue, Y., Yokoo, J., Kimura, Y., Kato, N. (1989) Retention of bacterial lipopolysaccharide at the site of subcutaneous injection. Infect. Immun. 57, 1786-1791.
123. Harris, H. W., Grunfeld, C., Feingold, K. R., Read, T. E., Kane, J. P., Jones, A. L., Eichbaum, E. B., Bland, G. F., Rapp, J. H. (1993) Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest. 91, 1028-1034.
124. Spitzer, A. L., Chuang, K. I., Victorino, G. P., Kasravi, B., Curran, B., Lee, D., Harris, H. W. (2011) Chylomicrons combined with endotoxin moderate microvascular permeability. Innate Immun. 17, 283-292.
125. Netea, M. G., Demacker, P. N., Kullberg, B. J., Jacobs, L. E., Verver-Jansen, T. J., Boerman, O. C., Stalenhoef, A. F., Van der Meer, J. W. (1998) Bacterial lipopolysaccharide binds and stimulates cytokineproducing cells before neutralization by endogenous lipoproteins can occur. Cytokine 10, 766-772.
126. Kitchens, R. L., Thompson, P. A., Viriyakosol, S., O’Keefe, G. E., Munford, R. S. (2001) Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J. Clin. Invest. 108, 485-493.
127. Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (1999) Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J. Biol. Chem. 274, 34116-34122.
128. Hiki, N., Berger, D., Dentener, M. A., Mimura, Y., Buurman, W. A., Prigl, C., Seidelmann, M., Tsuji, E., Kaminishi, M., Beger, H. G. (1999) Changes in endotoxin-binding proteins during major elective surgery: important role for soluble CD14 in regulation of biological activity of systemic endotoxin. Clin. Diagn. Lab. Immunol. 6, 844-850.
129. Gioannini, T. L., Teghanemt, A., Zhang, D., Prohinar, P., Levis, E. N., Munford, R. S., Weiss, J. P. (2007) Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by acyloxyacyl hydrolase. J. Biol. Chem. 282, 7877-7884.
130. Elsbach, P. (2000) Mechanisms of disposal of bacterial lipopolysaccharides by animal hosts. Microbes Infect. 2, 1171-1180.
131. Elsbach, P., Weiss, J. (1993) The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 187, 417-429.
132. Dentener, M. A., Von Asmuth, E. J. U., Francot, G. J. M., Marra, M. N., Buurman, W. A. (1993) Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. J. Immunol. 151, 4258-4265.
133. Bucki, R., Georges, P. C., Espinassous, Q., Funaki, M., Pastore, J. J., Chaby, R., Janmey, P. A. (2005) Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44, 9590-9597.
134. Drago-Serrano, M. E., de la Garza-Amaya, M., Luna, J. S., Campos-Rodríguez, R. (2012) Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects. Int. Immunopharmacol. 12, 1-9.
135. Braun, J. M., Blackwell, C. C., Poxton, I. R., El Ahmer, O., Gordon, A. E., Madani, O. M., Weir, D. M., Giersen, S., Beuth, J. (2002) Proinflammatory responses to lipo-oligosaccharide of Neisseria meningitidis immunotype strains in relation to virulence and disease. J. Infect. Dis. 185, 1431-1438.
136. Youn, J. H., Oh, Y. J., Kim, E. S., Choi, J. E., Shin, J. S. (2008) High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J. Immunol. 180, 5067-5074.
137. Brandtzaeg, P., Osnes, L., Ovstebø, R., Joø, G. B., Westvik, A.-B., Kierulf, P. (1996) Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J. Exp. Med. 184, 51-60.
138. Gopinathan, U., Brusletto, B. S., Olstad, O. K., Kierulf, P., Berg, J. P., Brandtzaeg, P., Øvstebø, R. (2015) IL-10 immunodepletion from meningococcal sepsis plasma induces extensive changes in gene expression and cytokine release in stimulated human monocytes. Innate Immun. 21, 429-449.
139. Collins, P. E., Carmody, R. J. (2015) The regulation of endotoxin tolerance and its impact on macrophage activation. Crit. Rev. Immunol. 35, 293-323.
140. Marie, C., Muret, J., Fitting, C., Losser, M. R., Payen, D., Cavaillon, J. M. (1998) Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood 91, 3439-3446.
141. Demaret, J., Venet, F., Friggeri, A., Cazalis, M.-A., Plassais, J., Jallades, L., Malcus, C., Poitevin-Later, F., Textoris, J., Lepape, A., Monneret, G. (2015) Marked alterations of neutrophil functions during sepsisinduced immunosuppression. J. Leukoc. Biol. 98, 1081-1090.
142. Levels, J. H., Lemaire, L. C., van den Ende, A. E., van Deventer, S. J., van Lanschot, J. J. (2003) Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure. Crit. Care Med. 31, 1647-1653.
143. Kitchens, R. L., Thompson, P. A., Munford, R. S., O’Keefe, G. E. (2003) Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J. Lipid Res. 44, 2339-2348.
144. Froon, A. H. M., Dentener, M. A., Greve, J. W. M., Ramsay, G., Buurman, W. A. (1995) Lipopolysaccharide toxicity-regulating proteins in bacteremia. J. Infect. Dis. 171, 1250-1257.
145. Hamann, L., Alexander, C., Stamme, C., Zähringer, U., Schumann, R. R. (2005) Acute-phase concentrations of lipopolysaccharide (LPS)- binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect. Immun. 73, 193-200.
146. Thompson, P. A., Tobias, P. S., Viriyakosol, S., Kirkland, T. N., Kitchens, R. L. (2003) Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J. Biol. Chem. 278, 28367-28371.
147. Navab, M., Hough, G. P., Van Lenten, B. J., Berliner, J. A., Fogelman, A. M. (1988) Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. J. Clin. Invest. 81, 601-605.
148. Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermúdez-Humarán, L. G., Smirnova, N., Bergé, M., Sulpice, T., Lahtinen, S., Ouwehand, A., Langella, P., Rautonen, N., Sansonetti, P. J., Burcelin, R. (2011) Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 3, 559-572.
149. Jiang, W., Lederman, M. M., Hunt, P., Sieg, S. F., Haley, K., Rodriguez, B., Landay, A., Martin, J., Sinclair, E., Asher, A. I., Deeks, S. G., Douek, D. C., Brenchley, J. M. (2009) Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199, 1177-1185.
150. Shimizu, T., Tani, T., Endo, Y., Hanasawa, K., Tsuchiya, M., Kodama, M. (2002) Elevation of plasma peptidoglycan and peripheral blood neutrophil activation during hemorrhagic shock: plasma peptidoglycan reflects bacterial translocation and may affect neutrophil activation. Crit. Care Med. 30, 77-82.
151. Clarke, T. B., Davis, K. M., Lysenko, E. S., Zhou, A. Y., Yu, Y., Weiser, J. N. (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16, 228-231.
152. Kim, O. Y., Monsel, A., Bertrand, M., Cavaillon, J. M., Coriat, P., Adib-Conquy, M. (2009) Translocation of bacterial NOD2 agonist and its link with inflammation. Crit. Care 13, R124.